Supporting Rare Disease Innovation with Compliant, High-Quality Sample Sourcing
Rare oncology indications from solid tumours to malignant haematological diseases represent one of the most pressing unmet medical needs worldwide. With over 7,000 rare diseases identified globally and nearly 45% of recent European drug approvals classified as orphan medicines, innovation in rare disease research is accelerating at pace.
Advances in genomics, next-generation sequencing (NGS), and precision medicine are transforming oncology. Biomarker-driven trials, molecular stratification strategies, and translational research programmes all depend on one critical factor: access to high-quality, ethically sourced human biological samples. When patient populations are limited, every sample matters.
At Tebubio, they help researchers secure the biological materials they need reliably, compliantly, and without operational friction, so you can focus on discovery.
Human Sample Sourcing, Simplified and De‑Risked by Tebubio
Sourcing human biological samples should not slow down your science. Tebubio de-risks and streamlines your procurement process at every step:
Global Biobank Network
They collaborate with a trusted international network of biobanks and clinical partners that meet strict ethical and quality standards, expanding your access to rare and well-characterised cohorts.
EU-Compliant Sourcing
They manage all relevant European compliance and documentation, ensuring that samples are ethically approved for research use and handled according to the highest regulatory standards.
Fully Authorised Import & Export
Every cross-border transfer complies with French Ministry of Research procedures and EU-level expectations. No customs uncertainty. No regulatory surprises.
Full Product Traceability
From temperature-controlled logistics to customs handling, they ensure seamless delivery to your laboratory with documented traceability.
Reduced Sourcing Variability
Their curated supplier selection ensures consistent quality standards across batches, reducing variability that may compromise reproducibility.
One Expert Point of Contact
They centralise communication, coordination, and after-sales support through a dedicated specialist.
Proactive Risk Anticipation
They identify and resolve ethical, regulatory, and operational challenges before they impact your timelines.
What Do They Offer?
Their approach is built around your study design, timelines, and scientific objectives.
Biobank Selection
If you face a short project timeline or immediate need, they rapidly identify suitable biobanks within our global network to broaden your access to rare samples.
Prospective Collection
Defined inclusion and exclusion criteria? They conduct a qualification discussion to understand your project scope and organise prospective collections tailored to your research protocol.
Patient Conditions
Access to both healthy donors and oncology patients, including rare and complex disease profiles.
Matched Samples
Need paired materials for comparative analyses or longitudinal research? They source matched samples aligned with your study requirements.
Mutation Status
Some partner biobanks provide known mutation status. Alternatively, they coordinate NGS testing alongside sample procurement.
Sample Types Available
They provide access to a comprehensive range of oncology-relevant materials:
If you require a specific processing method, preservation protocol, or clinical annotation dataset, they will assess feasibility with our partners.
Supporting Your Research Every Step of the Way
Why Work With Tebubio?
Designed Around Your Research Needs
Whether you are:
Tebubio ensures your access to compliant, high-quality samples does not become a bottleneck.
Let’s Discuss Your Project
Whether you have an urgent requirement or are preparing your next rare oncology study, Inês Santarino, your Product Manager at Tebubio, is available for a qualification call to assess your needs.
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Many repetitive regions of the genome have been considered “junk DNA...
